title: Inhibition of proprotein convertase subtilisin/kexin type 9 in the treatment of hypercholesterolemia.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, departamento de Medicina, Universitat de Valencia, INCLIVA, CIBERDEM, presidente de la Sociedad Española de Arteriosclerosis. Electronic address: ascaso@uv.es.
authors.forename: Juan F
authors.initials: JF
authors.lastname: Ascaso
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000145:classification / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D004705:Endocytosis; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D006938:Hyperlipoproteinemia Type II / Q000235:genetics; D015201:Meta-Analysis as Topic; D058990:Molecular Targeted Therapy; D000091362:PCSK9 Inhibitors; D000071449:Proprotein Convertase 9 / Q000235:genetics / Q000276:immunology / Q000502:physiology; D011973:Receptors, LDL / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D000091362:PCSK9 Inhibitors; D011973:Receptors, LDL; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9